ClinConnect ClinConnect Logo
Search / Trial NCT06377956

The Associations Between Gut Length, Gut Microbiota and Food Assimilation

Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · Apr 17, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Metabolism Microbiome/Microbiota Body Composition Food Intake Food Preference

ClinConnect Summary

This clinical trial is looking at how the length of our intestines, the tiny bacteria living in our gut, and how well we absorb energy from food are all connected. The goal is to understand these relationships better, particularly in healthy individuals. By studying these factors, researchers hope to gain insights that could help with nutrition and managing conditions like metabolic syndrome, which affects how our bodies use energy.

To join this study, participants need to be between 18 and 40 years old, healthy, and without any diseases. They should have a healthy body weight and regular bowel movements. However, people with certain health issues, such as digestive disorders or mental health conditions, or those who have recently taken specific medications, will not be eligible. Participants can expect to provide information about their diet and health, and they may undergo some tests to help researchers gather data. This research is currently seeking volunteers, so if you meet the criteria, you could play a role in advancing our understanding of nutrition and gut health!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18-40 years old, healthy and disease free.
  • BMI ≥ 18.5;
  • Regular bowel movements.
  • Exclusion Criteria:
  • Individuals who are constipated or suffer from intestinal disorders;
  • Individuals with mental illnesses such as depression and claustrophobia;
  • Individuals with glaucoma and prostate hypertrophy;
  • Metal implants in the body;
  • Pregnant and lactating women;
  • Individuals with blood phobia, pathologic hypotension or hypertension;
  • Use of antibiotics, probiotics, oral laxatives within 8 weeks;
  • Individuals with metabolic diseases (e.g., chronic diseases such as diabetes mellitus); recent weight loss due to various medical reasons;
  • Individuals with infectious diseases (e.g. HIV);
  • Irregular diet, lifestyle, addiction to tobacco, alcohol or drugs.

About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences

The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.

Locations

Shenzhen, Guangdong, China

Patients applied

0 patients applied

Trial Officials

John R Speakman, PhD

Study Chair

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported